United States Food and Drug Administration
"United States Food and Drug Administration" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
An agency of the PUBLIC HEALTH SERVICE concerned with the overall planning, promoting, and administering of programs pertaining to maintaining standards of quality of foods, drugs, therapeutic devices, etc.
| Descriptor ID |
D014486
|
| MeSH Number(s) |
I01.409.418.750.600.650.760 N03.540.348.500.500.600.650.760
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "United States Food and Drug Administration".
Below are MeSH descriptors whose meaning is more specific than "United States Food and Drug Administration".
This graph shows the total number of publications written about "United States Food and Drug Administration" by people in this website by year, and whether "United States Food and Drug Administration" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1997 | 0 | 1 | 1 |
| 1999 | 0 | 1 | 1 |
| 2000 | 0 | 2 | 2 |
| 2001 | 0 | 1 | 1 |
| 2003 | 0 | 2 | 2 |
| 2004 | 0 | 5 | 5 |
| 2005 | 0 | 3 | 3 |
| 2006 | 0 | 1 | 1 |
| 2007 | 2 | 4 | 6 |
| 2008 | 0 | 2 | 2 |
| 2009 | 1 | 5 | 6 |
| 2010 | 0 | 3 | 3 |
| 2011 | 1 | 3 | 4 |
| 2012 | 2 | 4 | 6 |
| 2013 | 1 | 0 | 1 |
| 2014 | 2 | 4 | 6 |
| 2015 | 1 | 3 | 4 |
| 2016 | 3 | 9 | 12 |
| 2017 | 0 | 5 | 5 |
| 2018 | 1 | 4 | 5 |
| 2019 | 0 | 6 | 6 |
| 2020 | 1 | 4 | 5 |
| 2021 | 0 | 4 | 4 |
| 2022 | 0 | 5 | 5 |
To return to the timeline,
click here.
Below are the most recent publications written about "United States Food and Drug Administration" by people in Profiles.
-
Electronic nicotine delivery systems (ENDS) flavours and devices used by adults before and after the 2020 US FDA ENDS enforcement priority: findings from the 2018 and 2020 US ITC Smoking and Vaping Surveys. Tob Control. 2022 Nov; 31(Suppl 3):s167-s175.
-
Medicare Spending on Drugs With Accelerated Approval. Ann Intern Med. 2022 07; 175(7):938-944.
-
Demographic Disparities in the Federal Drug Approval Process for Allergic Rhinitis Medications. Laryngoscope. 2023 Apr; 133(4):755-763.
-
Single-arm clinical trials that supported FDA accelerated approvals have modest effect sizes and were at high risk of bias. J Clin Epidemiol. 2022 08; 148:193-195.
-
Translating Research into Health Policy: The Citizen Petition Experience with the Food and Drug Administration. Cancer Treat Res. 2022; 184:61-73.
-
A visual and narrative timeline of US FDA milestones for Transcranial Magnetic Stimulation (TMS) devices. Brain Stimul. 2022 Jan-Feb; 15(1):73-75.
-
Considerations from the College of American Pathologists for Implementation of an Assay for SARS-CoV-2 Testing after a Change in Regulatory Status. J Clin Microbiol. 2021 09 20; 59(10):e0116721.
-
The problematic lag between FDA approval of medical devices and CMS coverage. J Cardiovasc Electrophysiol. 2021 07; 32(7):1801-1802.
-
Race and Pharmacogenomics-Personalized Medicine or Misguided Practice? JAMA. 2021 Feb 16; 325(7):625-626.
-
Improving oncology biosimilar launches in the EU, the USA, and Japan: an updated Policy Review from the Southern Network on Adverse Reactions. Lancet Oncol. 2020 12; 21(12):e575-e588.